Michael F. DeMane - 30 Dec 2022 Form 4 Insider Report for NEVRO CORP

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Michael DeMane
Issuer symbol
N/A
Transactions as of
30 Dec 2022
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 15:36:01 UTC
Previous filing
04 Oct 2022
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Award $0 +662 +3.4% $0.000000 20,001 30 Dec 2022 Direct F1, F2
holding NVRO Common Stock 164,344 30 Dec 2022 See footnote F3
holding NVRO Common Stock 82,541 30 Dec 2022 See footnote F4
holding NVRO Common Stock 91,225 30 Dec 2022 See footnote F5, F7
holding NVRO Common Stock 18,266 30 Dec 2022 See footnote F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested restricted stock. The restricted stock represent quarterly retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.
F2 Includes 4,155 restricted stock units.
F3 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
F4 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
F5 Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011 (the "2011 Trust").
F6 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021 (the "2021 Trust").
F7 Reflects the transfer of 31,645 shares from the 2021 Trust to the 2011 Trust on November 18, 2022.